Semaglutide is really making waves in the field of weight management for its promising results in appetite suppression and weight loss
GLP-1 receptor agonists delay gastric emptying and can reduce GI motility , which helps regulate postprandial glucose levels and promotes satiety
Given that GLP-1-RAs alter gut motility and secretion, and that the gut microbiota can influence host eating behavior, including food preferences, it is plausible that these drugs indirectly influence taste perception by modulating microbial composition and the subsequent production of metabolites that can signal to the brain, potentially via vagal afferents or systemic circulation
This way, you get the most benefit and lower the risks
That said, practitioners and researchers have developed working conversion estimates based on trial outcomes and clinical experience
Conclusions Consistent with clinical trials, real-world tirzepatide treatment was associated with greater 6-month weight reduction and more frequent achievement of weight-reduction targets and improvements in select cardiometabolic parameters than semaglutide among adults with obesity without diabetes
